Protocolo de Prevenção e Tratamento de Infeções Associadas à Terapêutica Imunossupressora de Doenças Autoimunes Guideline
Ano de última actualização: 2021
DOWNLOAD
Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies | Clinical Microbiology Reviews
Ano de última actualização: 2020
https://journals.asm.org/doi/10.1128/cmr.00035-19
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors) – ScienceDirect
Ano de última actualização: 2018
https://www.sciencedirect.com/science/article/pii/S1198743X18301484
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors) – ScienceDirect
Ano de última actualização: 2018
https://www.sciencedirect.com/science/article/pii/S1198743X18301824
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents) – ScienceDirect
Ano de última actualização: 2018
https://www.sciencedirect.com/science/article/pii/S1198743X18300302
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors) – ScienceDirect
Ano de última actualização: 2018
https://www.sciencedirect.com/science/article/pii/S1198743X18301502
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52) – ScienceDirect
Ano de última actualização: 2018
https://www.sciencedirect.com/science/article/pii/S1198743X18301514
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Cell surface receptors and associated signaling pathways) – ScienceDirect
Ano de última actualização: 2018
https://www.sciencedirect.com/science/article/pii/S1198743X18300326
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4) – ScienceDirect
https://www.sciencedirect.com/science/article/pii/S1198743X18302325